Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Satake Multimix is a Japanese manufacturer of mixing, agitation, environmental testing, and classification equipment that evolved from the former Satake Chemical Equipment Manufacturing. While the company is primarily an industrial equipment supplier rather than a therapeutics developer, it has expanded into bioprocessing and regenerative medicine support through cell culture devices and single-use bioreactor systems. Its bio business has supported partners working on iPS cell-derived platelets, gene-edited NK cells, and cell therapy manufacturing processes. The company appears to generate revenue from equipment sales, engineering, and manufacturing rather than from a proprietary drug pipeline. For healthcare and life sciences, Satake Multimix is best characterized as a tools/platform enabler for cell therapy and regenerative medicine manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Satake Multimix.